Nasdaq Biotechnology Ishares ETF (IBB)
$137.26
0.65 (0.47%)
IBB Stock Quote Delayed 30 Minutes
S&P 500, Nasdaq Take a Licking as Economic Doubts Grow
Biotechs, semiconductors and financials among the worst-hit stocks in Wednesday's economic data-driven selloff.
Top 5 Stocks for 2024
INSIDE: Investing legend Louis Navellier reveals his Top 5 Stocks for 2024 — FREE!
Download His Free Report Here:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Unlock Louis Navellier's
? Stock Report – FREE:
Is ? a BUY?
Powered by Portfolio Grader
A
B
C
D
F
?
Unlock Louis Navellier's
? Stock Report to Find Out – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Investing legend Louis Navellier rates ? a "?." Unlock his ? Stock Analysis to find out why – FREE:
Louis Navellier's Total Grade
Powered by Portfolio Grader?
Fundamental Grade
Quantitative Grade
- Sales Growth ?
- Operating Margin Growth ?
- Earnings Growth ?
- Earnings Momentum ?
- Earnings Surprises ?
- Analyst Earnings Revisions ?
- Cash Flow ?
- Return on Equity ?
Previous Close
-
Market Cap
-
PE Ratio
-
EPS
-
Volume (Avg. Vol.)
1.28M
Day's Range
$136.42 - $138.33
52-Week Range
$111.83 - $141.16
Dividend & Yield
$0.61 (0.45%)
IBB Stock Predictions, Articles, and Nasdaq Biotechnology Ishares ETF News
Biotech, Blue-Chip Tech Buckle as Nasdaq Cedes 5K
Microsoft (MSFT), Micron (MU) and biotechs (IBB) took a slide in Tuesday trading. Investors should continue to exercise caution at these highs.
Play the Biotech Boom With IBB
Biotech bulls continue to charge forward, sending IBB higher. Capitalize on the biotech sector breakout with call spreads in the IBB ETF.
FOMC, Oil Rebound Shake the Bulls Awake
Despite the bounce in stocks, bonds, credit and currencies were not singing the same tune, and instead continued to warn of deeper woes.
Trade of the Day: IBB Up 40% YTD – Buy, Sell or Hold?
The strong advance in iShares NASDAQ Biotechnology Index ETF has been volatile.
4 Biggest Trends in 2014 Investing
Commodities, healthcare stocks, long-term bonds and Russian stocks were four of the biggest investing themes of 2014.
Stocks Inch to New Records, But Who the Heck Is Buying?
The S&P 500 and Dow Jones finished at new highs, but a lack of market breadth during this rebound remains a problem.
3 Innovative Biotech Stocks to Diversify Your Portfolio
Echo Therapeutics (ECTE), Theralase Technologi (TLTFF) and Tribute Pharmaceuticals Canada (TBUFF) are biotech stocks to buy.
Great Biotech Stocks for Retirement Investors
Yes, Biotech stocks DO belong in your retirement portfolio. Here are three ways to add them and reap the rewards.
Put Some of Your Accumulated Cash To Work
The S&P 500 has penetrated overhead resistance with a fresh buy signal.
Biotech is the Best Buy in This Market
Bargain hunters should focus on biotechs since momentum is clearly on their side.
If You’ve Got Trading Discipline, Now’s the Time to Exercise It
This market is overvalued, and we're approaching a historically difficult time for stocks. You can stay long, but stay cautious, too.
Major Breakout Occurring While Public Cries Wolf
The S&P 500 continues to reach new heights in the face of investor disbelief.
The Most Important Chart to Watch Right Now
Small caps hold the key to the future direction of the broader market.
Search for Value in Market’s Most Troublesome Sectors
Tech and biotech have shown real progress in making solid bases from which they can move higher.
Dow Theory Buy Signal Confirmed
The industrials broke to a new closing high, putting the pressure on the bears.
Don’t Bet on a Bottom Being Put in Here
Technical failures, internal indicators, investor sentiment and history all point to more selling ahead.
Ready, Aim, Bargain Hunt
Those with a good risk tolerance should use the current weakness to buy high-quality, oversold stocks.
